Frans van Dalen is a Founding Partner at Meneldor, bringing over 30 years of experience in the (bio)pharmaceutical industry. Since 1992, he has been a founding partner of the Synthon group of companies, contributing to its growth to over 1,500 employees across nine global locations. He played a central role in the development, regulatory strategy, manufacturing, and commercialization of generic medicines, biosimilars, and novel biological entities. His expertise enables him to identify high-potential technologies early and guide companies through pharmaceutical development, from discovery through approval and market entry.
BioTech, BioPharma
Direct Professional Email Pattern
AI Outreach Agent Pitch Writer
Compose an personalized, high-converting outreach message targeting their exact investment interest...